$TGAAU

2022 Q4 Form 10-K Financial Statement

#000119312523081999 Filed on March 28, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $31.75K $1.097M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $31.75K $1.097M
YoY Change -81.48% 504.55%
Operating Profit -$1.097M
YoY Change
Interest Expense $1.853M $3.031M
YoY Change 19325.79% 31667.61%
% of Operating Profit
Other Income/Expense, Net $0.00 $30.21K
YoY Change -100.0% -49.65%
Pretax Income $1.821M $1.963M
YoY Change -1887.15% -1853.19%
Income Tax
% Of Pretax Income
Net Earnings $1.821M $1.963M
YoY Change -1887.15% -1853.19%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.07 $0.07
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $394.3K $394.3K
YoY Change -60.81% -60.81%
Cash & Equivalents $394.3K
Short-Term Investments
Other Short-Term Assets $111.7K $111.7K
YoY Change -44.26% -44.26%
Inventory
Prepaid Expenses $111.7K
Receivables
Other Receivables
Total Short-Term Assets $506.0K $506.0K
YoY Change -58.06% -58.06%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $222.2M $222.2M
YoY Change 1.38% 1.38%
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $222.2M $222.2M
YoY Change 1.31% 1.31%
TOTAL ASSETS
Total Short-Term Assets $506.0K $506.0K
Total Long-Term Assets $222.2M $222.2M
Total Assets $222.7M $222.7M
YoY Change 0.98% 0.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $157.8K $157.8K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $500.0K $500.0K
YoY Change 1085.96% 1085.96%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $785.2K $785.2K
YoY Change 34.8% 34.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $7.521M $7.521M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $7.521M $7.521M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $785.2K $785.2K
Total Long-Term Liabilities $7.521M $7.521M
Total Liabilities $8.307M $8.307M
YoY Change 2.5% 2.5%
SHAREHOLDERS EQUITY
Retained Earnings -$7.801M
YoY Change 16.01%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.801M $214.4M
YoY Change
Total Liabilities & Shareholders Equity $222.7M $222.7M
YoY Change 0.98% 0.98%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $1.821M $1.963M
YoY Change -1887.15% -1853.19%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$414.1K -$1.070M
YoY Change 1508.23% 4054.05%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 500.0K 457.8K
YoY Change -99.77% -99.79%
NET CHANGE
Cash From Operating Activities -414.1K -1.070M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 500.0K 457.8K
Net Change In Cash 85.88K -611.8K
YoY Change -91.46% -160.81%
FREE CASH FLOW
Cash From Operating Activities -$414.1K -$1.070M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001847355
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
CY2022 dei Entity Address Country
EntityAddressCountry
KY
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41135
CY2022 dei Entity Registrant Name
EntityRegistrantName
TARGET GLOBAL ACQUISITION I CORP.
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
PO BOX 10176
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
GOVERNOR’S SQUARE
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
23 LIME TREE BAY AVENUE
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1002
CY2022 dei City Area Code
CityAreaCode
345
CY2022 dei Local Phone Number
LocalPhoneNumber
814 5772
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
212962.511
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2022Q4 us-gaap Cash
Cash
394251
CY2021Q4 us-gaap Cash
Cash
1006074
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
111739
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
200478
CY2022Q4 us-gaap Assets Current
AssetsCurrent
505990
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1206552
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
163973
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
222234685
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
219204052
CY2022Q4 us-gaap Assets
Assets
222740675
CY2021Q4 us-gaap Assets
Assets
220574577
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
157805
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
502745
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
127419
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
7419
CY2022Q4 tgaau Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
500000
CY2021Q4 tgaau Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
42156
CY2021Q4 tgaau Over Allotment Liability Current
OverAllotmentLiabilityCurrent
30207
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
785224
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
582527
CY2022Q4 tgaau Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7521380
CY2021Q4 tgaau Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7521380
CY2022Q4 us-gaap Liabilities
Liabilities
8306604
CY2021Q4 us-gaap Liabilities
Liabilities
8103907
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
222234685
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
219194512
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7801151
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6724379
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7800614
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6723842
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222740675
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220574577
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1097439
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
181531
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1097439
us-gaap Operating Income Loss
OperatingIncomeLoss
-181531
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3030633
us-gaap Investment Income Interest
InvestmentIncomeInterest
9540
CY2022 tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
30207
tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
60000
CY2022 us-gaap Other Income
OtherIncome
3060840
us-gaap Other Income
OtherIncome
69540
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1963401
us-gaap Net Income Loss
NetIncomeLoss
-111991
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10595863
tgaau Adjustments To Additional Paid In Capital Proceeds Allocated To Public Warrants
AdjustmentsToAdditionalPaidInCapitalProceedsAllocatedToPublicWarrants
2865288
tgaau Adjustments To Additional Paid In Capital Warrants Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedIssuanceCosts
-225958
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
19901836
tgaau Reduction Of Over Allotment Liability Due To Partial Exercise
ReductionOfOverAllotmentLiabilityDueToPartialExercise
29792
us-gaap Net Income Loss
NetIncomeLoss
-111991
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6723842
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3040173
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1963401
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7800614
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1963401
us-gaap Net Income Loss
NetIncomeLoss
-111991
tgaau Formation Cost Paid By Sponsor
FormationCostPaidBySponsor
10072
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3030633
us-gaap Investment Income Interest
InvestmentIncomeInterest
9540
CY2022 tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
30207
tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
60000
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-252712
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
364451
CY2022 tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
-344940
tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
502745
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
120000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
7419
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1069667
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25746
tgaau Investments Held In Trust
InvestmentsHeldInTrust
-219194512
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-219194512
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
209588313
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10595863
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
457844
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
42156
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
457844
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
220226332
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-611823
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1006074
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1006074
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394251
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1006074
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3040173
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
219194512
tgaau Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
14928
tgaau Deferred Underwriters Discount Payable Charged To Additional Paid In Capital
DeferredUnderwritersDiscountPayableChargedToAdditionalPaidInCapital
7521380
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-02-02
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14896580
CY2022Q4 tgaau Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.2
CY2021Q4 tgaau Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2022Q4 tgaau Cash Outside The Trust Account
CashOutsideTheTrustAccount
394251
CY2022Q4 tgaau Working Capital Deficit
WorkingCapitalDeficit
279234
CY2022 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
500000
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
500000
CY2022 tgaau Redeemable Percentage Of Outstanding Public Shares
RedeemablePercentageOfOutstandingPublicShares
1
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</div>
CY2022Q4 us-gaap Cash
Cash
394251
CY2021Q4 us-gaap Cash
Cash
1006074
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
219194512
CY2021Q4 tgaau Restricted Investments Term
RestrictedInvestmentsTerm
P185D
tgaau Percentage Of Shares Issuable Upon Conversion
PercentageOfSharesIssuableUponConversion
50
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
500000
CY2022 tgaau Offering Proceeds Allocated To Offering Expenses
OfferingProceedsAllocatedToOfferingExpenses
1000000
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
500000
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
42156
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
127419
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
7419
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 tgaau Number Of Days After Consummation Of Business Combination Within Which The Securities Shall Be Registered
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichTheSecuritiesShallBeRegistered
P20D
CY2022 tgaau Number Of Days After Which Business Combination Within Which Securities Registration Shall Be Effective
NumberOfDaysAfterWhichBusinessCombinationWithinWhichSecuritiesRegistrationShallBeEffective
P60D
CY2021Q4 tgaau Class Of Warrants And Rights Issued During The Period
ClassOfWarrantsAndRightsIssuedDuringThePeriod
13333333
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
222234685
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
219179096

Files In Submission

Name View Source Status
0001193125-23-081999-index-headers.html Edgar Link pending
0001193125-23-081999-index.html Edgar Link pending
0001193125-23-081999.txt Edgar Link pending
0001193125-23-081999-xbrl.zip Edgar Link pending
d391384d10k.htm Edgar Link pending
d391384dex311.htm Edgar Link pending
d391384dex312.htm Edgar Link pending
d391384dex321.htm Edgar Link pending
d391384dex322.htm Edgar Link pending
d391384dex41.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tgaau-20221231.xsd Edgar Link pending
tgaau-20221231_cal.xml Edgar Link unprocessable
tgaau-20221231_def.xml Edgar Link unprocessable
tgaau-20221231_lab.xml Edgar Link unprocessable
tgaau-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d391384d10k_htm.xml Edgar Link completed